Unjha Formulations Intrinsic Value

UNJHAFOR • Healthcare
Current Stock Price
₹23.97
Primary Intrinsic Value
₹50.60
Market Cap
₹12.0 Cr
+48.2% Upside
Median Value
₹35.53
Value Range
₹12 - ₹51
Assessment
Trading Below Calculated Value
Safety Margin
32.5%

UNJHAFOR Valuation Methods Summary

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹50.60 ₹40.48 - ₹60.72 +111.1% EPS: ₹2.30, Sector P/E: 22x
Book Value Method asset ₹12.00 ₹10.80 - ₹13.20 -49.9% Book Value/Share: ₹6.00, P/B: 2.0x
Revenue Multiple Method revenue ₹47.94 ₹43.15 - ₹52.73 +100.0% Revenue/Share: ₹28.00, P/S: 2.0x
EBITDA Multiple Method earnings ₹19.90 ₹17.91 - ₹21.89 -17.0% EBITDA: ₹1.00Cr, EV/EBITDA: 10x
PEG Ratio Method growth ₹36.80 ₹33.12 - ₹40.48 +53.5% EPS Growth: 20.0%, Fair P/E: 16.0x
Growth Adjusted P/E growth ₹35.53 ₹31.98 - ₹39.08 +48.2% Revenue Growth: 6.0%, Adj P/E: 15.5x
ROE Based Valuation profitability ₹32.00 ₹28.80 - ₹35.20 +33.5% ROE: 33.3%, P/E Multiple: 16x
Graham Defensive Method conservative ₹12.00 ₹10.80 - ₹13.20 -49.9% EPS: ₹2.30, BVPS: ₹6.00
Method Types: Earnings Asset DCF Growth Dividend Conservative

Want to compare with current market value? Check UNJHAFOR share price latest .

Valuation Comparison Chart

UNJHAFOR Intrinsic Value Analysis

What is the intrinsic value of UNJHAFOR?

Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Unjha Formulations (UNJHAFOR) is ₹35.53 (median value). With the current market price of ₹23.97, this represents a +48.2% variance from our estimated fair value.

The valuation range spans from ₹12.00 to ₹50.60, indicating ₹12.00 - ₹50.60.

Is UNJHAFOR undervalued or overvalued?

Based on our multi-method analysis, Unjha Formulations (UNJHAFOR) appears to be trading below calculated value by approximately 48.2%.

Financial Health Analysis

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Debt to Equity Ratio 1.67 Industry Standard: <0.5 Above 1.0 Indicates financial leverage level
Return on Equity 33.3% Industry Standard: 15%+ Above 15% Measures shareholder return efficiency
Operating Margin 6.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 2.80x Industry Standard: 1.0x+ Above 1.0x Measures asset utilization efficiency

Cash Flow Quality Analysis

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2024 ₹1 Cr ₹1 Cr Positive Free Cash Flow 8/10
March 2023 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2022 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2021 ₹-1 Cr ₹-1 Cr Negative Cash Flow 3/10